We assumed that clusterin might play a protective role (as a compensatory mechanism) in psoriasis, metabolic syndrome, and other inflammatory (e.g., rheumatoid arthritis and atopic dermatitis) and neurodegenerative (e.g., Alzheimer’s and Parkinson’s) diseases. This evidence concerns the gene CLU and metabolic syndrome.